Results 151 to 160 of about 3,335 (217)

Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer's Disease Therapy. [PDF]

Cells
Jarne-Ferrer J, Pallàs M, Griñán-Ferré C, Bellver-Sanchis A.   +3 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial. [PDF]

Int J Neuropsychopharmacol
Mueller MJ, Aicher HD, Dornbierer DA, Marten L, Suay D, Meling D, Elsner C, Wicki IA, Müller J, Poetzsch SN, Caflisch L, Hempe A, Steinhart CP, Puchkov M, Kost J, Landolt HP, Seifritz E, Quednow BB, Scheidegger M.   +18 more
europepmc   +1 more source

Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]

Cell Rep Med
Avram M, Borgwardt S.
europepmc   +1 more source

Smuggling of the Dimethyltryptamine Drug in the Ayahuasca Drink

Drug control, 2019
openaire   +1 more source

The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000-2025. [PDF]

Drug Alcohol Depend Rep
Darke S, Duflou J, Farrell M, Lappin J, Peacock A.   +4 more
europepmc   +1 more source

Dimethyltryptamine: endogenous role and therapeutic potential

, 2018
openaire   +2 more sources

Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. [PDF]

Neuropsychopharmacology
Erne L, Vogt SB, Müller L, Nuraj A, Becker A, Klaiber A, Zuparic M, Varghese N, Eckert A, Rudin D, Luethi D, Liechti ME.   +11 more
europepmc   +1 more source

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics. [PDF]

Front Psychiatry
Williams ML, Rudin D, Schmid Y, von Salm J.   +3 more
europepmc   +1 more source